...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO CEO Slides Up

Four of the slides PRESENTED at the showcase referred to "prostrate cancer".  This was corrected in the posted slides and I assume did not recur at BIO-CEO

Share
New Message
Please login to post a reply